Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
Chen NB, Qiu B, Zhang J, Qiang MY, Zhu YJ, Wang B, Guo JY, Cai LZ, Huang SM, Liu MZ, Li Q, Hu YH, Li QW, Liu H. Chen NB, et al. Among authors: guo jy. Cancer Res Treat. 2020 Jan;52(1):31-40. doi: 10.4143/crt.2018.624. Epub 2019 Apr 30. Cancer Res Treat. 2020. PMID: 31048664 Free PMC article.
Comparison of hyper- and hypofractionated radiation schemes with IMRT technique in small cell lung cancer: Clinical outcomes and the introduction of extended LQ and TCP models.
Li QW, Qiu B, Wang B, Zhang J, Chen L, Zhou Y, Qin JK, Guo SP, Xie WH, Hui ZG, Liang Y, Guo JY, Wang H, Zhu M, Shen WT, Duan LY, Chen LK, Zhang L, Long H, Wang YM, Liu H. Li QW, et al. Among authors: guo jy, guo sp. Radiother Oncol. 2019 Jul;136:98-105. doi: 10.1016/j.radonc.2019.03.035. Epub 2019 Apr 15. Radiother Oncol. 2019. PMID: 31015136
Investigating the loco-regional control of simultaneous integrated boost intensity-modulated radiotherapy with different radiation fraction sizes for locally advanced non-small-cell lung cancer: clinical outcomes and the application of an extended LQ/TCP model.
Qiu B, Li QW, Ai XL, Wang B, Huan J, Zhu ZF, Yu GH, Ji M, Jiang HH, Li C, Zhang J, Chen L, Guo JY, Zhou Y, Liu H. Qiu B, et al. Among authors: guo jy. Radiat Oncol. 2020 May 27;15(1):124. doi: 10.1186/s13014-020-01555-x. Radiat Oncol. 2020. PMID: 32460796 Free PMC article.
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study.
Li QW, Qiu B, Liang WH, Wang JY, Hu WM, Zhang T, Xu SB, López J, Chen NB, Guo MZ, Zhao Y, Chen LJ, Liu SR, Yun JP, Guo JY, Wang SY, Wang X, Zhang L, Yue DS, Liao ZX, Lin SH, Long H, Pang QS, Liu H. Li QW, et al. Among authors: guo jy, guo mz. J Cancer. 2020 Aug 25;11(20):6114-6121. doi: 10.7150/jca.47119. eCollection 2020. J Cancer. 2020. PMID: 32922551 Free PMC article.
Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Chen NB, Li QW, Zhu ZF, Wang YM, Cheng ZJ, Hui ZG, Guo SP, He HQ, Wang B, Huang XY, Li JB, Guo JY, Hu N, Ai XL, Zhou Y, Wang DQ, Liu FJ, Xie CM, Qiu B, Liu H. Chen NB, et al. Among authors: guo jy, guo sp. Radiat Oncol. 2020 Nov 10;15(1):260. doi: 10.1186/s13014-020-01704-2. Radiat Oncol. 2020. PMID: 33168045 Free PMC article.
591 results